KE · Kimball Electronics
AI read · Neutral
The AI's read
Cash from operations paid down debt, and medical sales grew in all 4 quarters of fiscal 2026. The company expects medical to make up over 33% of sales next year. But Q4 sales fell 2% from a year earlier, and operating income was $18.1 million, down from the prior year. Higher growth spending and tax costs weighed on the quarter. The expected sales growth and lower debt point in a positive direction, but lower recent sales and income point the other way. Together, the report gives no clear reason to change the company’s outlook.